http://www.w3.org/ns/prov#value | - The following is a notice of a basic agreement reached between Sawai Pharmaceutical Co., Ltd., Medisa Shinyaku Inc., Sumitomo Corporation and Summit Medi-Chem, Ltd. regarding the third-party allocation of new shares in Medisa Shinyaku Inc., which is a consolidated subsidiary of Sawai Pharmaceutical Co., Ltd., to be allocated to Sumitomo Corporation and Summit Medi-Chem, Ltd.
|